Please assess the completion status of the following clinical trial:

Trial Title: Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA class 1 or 2 (healthy patient or acute illness)~* Parental willingness to participate~* Candidate for pressure-equalization tubes (PET) as determined by the ENT department~Exclusion Criteria:~* ASA class 3 or 4 (chronic illness or life-threatening illness)~* Parental refusal to participate~* Significant liver disease by history~* Allergy to dexmedetomidine or midazolam~* Nasal deformity~* Fever in the three days prior to surgery~* Nausea or vomiting~* History of hypertension~* History of cardiac dysfunction/disorder~* Diabetes mellitus

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 5 Years
- Healthy Volunteers: t

Study Arms:
- saline (Type: PLACEBO_COMPARATOR): intranasal saline will be given 30 minutes prior to surgery
- dexmedetomidine (Type: EXPERIMENTAL): 2 mcg/kg dexmedetomidine will be given intranasally 30 minutes prior to surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).